Latest Insider Transactions at Paratek Pharmaceuticals, Inc. (PRTK)
This section provides a real-time view of insider transactions for Paratek Pharmaceuticals, Inc. (PRTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Paratek Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Paratek Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2020
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+10.84%
|
-
|
|
Nov 12
2020
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+12.26%
|
-
|
|
Nov 12
2020
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+10.11%
|
-
|
|
Oct 29
2020
|
Evan Loh CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,479
+6.26%
|
$157,916
$4.3 P/Share
|
|
Feb 02
2018
|
Michael Bigham Exec. Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
23,255
+1.68%
|
$93,020
$4.3 P/Share
|